Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Biochemistry. Biokhimiia
|
February 21, 2012
Pak6 protein kinase is a novel effector of an atypical Rho family GTPase Chp/RhoV
M V Shepelev, I V Korobko
Molekuliarnaia Biologiia
|
August 17, 2018
[Mutations in the Effector Domain of RhoV GTPase Impair Its Binding to Pak1 Protein Kinase]
I V Korobko, M V Shepelev
Molekuliarnaia Biologiia
|
August 25, 2021
[Combination of ARE and HRE cis- Regulatory Elements Elevates the Activity of Tumor-Specific hTERT Promoter]
S V Kalinichenko, I V Korobko, M V Shepelev
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia
|
November 11, 2006
[WIF1: perspectives of application in oncology]
M V Shepelev, E V Korobko, I V Korobko
Biochimica Et Biophysica Acta
|
December 17, 2013
mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells
P N Vikhreva, M V Shepelev, I V Korobko
Doklady. Biochemistry and Biophysics
|
June 16, 2019
Xenobiotic Response Elements (XREs) from Human CYP1A1 Gene Enhance the hTERT Promoter Activity
M V Shepelev, S V Kalinichenko, E K Saakian, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia
|
June 15, 2010
[Pdcd4 tumor suppressor: properties, functions, and their application to oncology]
P N Vikhreva, M V Shepelev, E V Korobko, et al.
Molekuliarnaia Biologiia
|
May 31, 2016
[Selection of microRNA for providing tumor specificity of transgene expression in cancer gene therapy]
M V Shepelev, S V Kalinichenko, P N Vikhreva, et al.
Acta Naturae
|
January 18, 2018
A Novel Hybrid Promoter ARE-hTERT for Cancer Gene Therapy
S V Kalinichenko, M V Shepelev, P N Vikhreva, et al.
Molekuliarnaia Biologiia
|
June 12, 2019
[Human Antithrombin III Minigene with an Optimized Splicing Pattern]
M V Shepelev, E K Saakian, S V Kalinichenko, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Biochemistry. Biokhimiia
|
February 21, 2012
Pak6 protein kinase is a novel effector of an atypical Rho family GTPase Chp/RhoV
M V Shepelev, I V Korobko
Molekuliarnaia Biologiia
|
August 17, 2018
[Mutations in the Effector Domain of RhoV GTPase Impair Its Binding to Pak1 Protein Kinase]
I V Korobko, M V Shepelev
Molekuliarnaia Biologiia
|
August 25, 2021
[Combination of ARE and HRE cis- Regulatory Elements Elevates the Activity of Tumor-Specific hTERT Promoter]
S V Kalinichenko, I V Korobko, M V Shepelev
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia
|
November 11, 2006
[WIF1: perspectives of application in oncology]
M V Shepelev, E V Korobko, I V Korobko
Biochimica Et Biophysica Acta
|
December 17, 2013
mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells
P N Vikhreva, M V Shepelev, I V Korobko
Doklady. Biochemistry and Biophysics
|
June 16, 2019
Xenobiotic Response Elements (XREs) from Human CYP1A1 Gene Enhance the hTERT Promoter Activity
M V Shepelev, S V Kalinichenko, E K Saakian, et al.
Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia
|
June 15, 2010
[Pdcd4 tumor suppressor: properties, functions, and their application to oncology]
P N Vikhreva, M V Shepelev, E V Korobko, et al.
Molekuliarnaia Biologiia
|
May 31, 2016
[Selection of microRNA for providing tumor specificity of transgene expression in cancer gene therapy]
M V Shepelev, S V Kalinichenko, P N Vikhreva, et al.
Acta Naturae
|
January 18, 2018
A Novel Hybrid Promoter ARE-hTERT for Cancer Gene Therapy
S V Kalinichenko, M V Shepelev, P N Vikhreva, et al.
Molekuliarnaia Biologiia
|
June 12, 2019
[Human Antithrombin III Minigene with an Optimized Splicing Pattern]
M V Shepelev, E K Saakian, S V Kalinichenko, et al.
Page
of 2